medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2006, Number 4

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2006; 4 (4)

Erythema multiforme

Asz-Sigall D, López-García L, Rojas-García P, Vega-Memije ME, Arenas R

Language: Spanish
References: 73
Page: 268-277
PDF size: 604.52 Kb.


ABSTRACT

Erythema multiforme (EM) is a hypersensibility reaction triggered by infectious agents (herpes simplex virus) and drugs. It is characterized by papules, pustules, vesicles, urticariform patches and iris-like erythema termed target lesions located in elbows, knees, palms and soles. It can be classify in EM minor when the course is benign, self limited, with minimal damage, and major when is severe with mucocutaneous necrosis and tendency to progress to the Stevens-Johnson syndrome (SJS). The separation of minor and major EM in two different conditions is still controversial because some authors consider EM major as a synonym of the Stevens-Johnson syndrome and others as two different entities.


REFERENCES

  1. Torres V, Camacho F, Mihm M et al. Dermatología práctica Ibero- Latinoamericana. Atlas, enfermedades sistémicas asociadas y terapéutica. México Imprelibros 2005: 469-473

  2. Arenas R. Dermatología. Atlas, diagnóstico y tratamiento. México Interamericana McGraw Hill 2004: 336-351

  3. Ayangco L, Rogers R. Oral manifestations of erythema multiforme. Dermatologic Clinics 2003; 21: 195-205

  4. Rappersberger K, Foedinger D. Treatment of erythema multiforme, Stevens- Johnson Syndrome and Toxic Epidermal Necrolysis. Dermatology Therapy 2002; 15: 397-408

  5. Farthing P, Bagan J-V, Scully. Erythema multiforme. Oral Diseases 2005; 11: 261-267

  6. Johnston GA, Ghura HS, Carter E et al. Neonatal erythema multiforme major. Clinical Dermatology 2002; 27: 661-664

  7. Forman R, Koren G, Shear N. Erythema Multiforme, Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Children. Drug Safety 2002; 25 (13): 965-972

  8. Léauté-labrèze C, Laminreau T, Chawki D et al. Diagnosis, classification, and management of erythema multiforme and Stevens-Johnson Syndrome. Archives of Disease in Childhood 2000; 83: 347-352

  9. Malo A, Kâmpgen E, Wank R. Recurrent Herpes Simples Virus-Induced Erythema Multiforme: Different HLA-DQB1 Alleles Asóciate with Severe Mucous Membrana Versus Skin Attaks. Scandinavian Journal of Inmunology 1998; 47: 408-411

  10. Kokuba H, Imafuku S, huang S et al. Erythema multiforme lesions are associated with expression of a herpes simplex virus (HSV) gene and qualitative alterations in the HSV-specific T-cell response. British Journal of Dermatology 1998; 138: 952-964

  11. Bateman T. A practical synopsis of cutaneous diseases. London: Longman, Hurst, Reese and Brown, 1814

  12. Rayer PF. Traité des maladies de la peau. Paris, 1835 (Cit. en 1)

  13. Saúl A. Lecciones de Dermatología. México Méndez Editores 2001: 455

  14. Von Hebra F, Kaposi M. On diseases of the skin including exantemas. Vol 1. London: New Sydenham Society, 1866; 449-494 (Cit. en 1)

  15. Hebra F, Kaposi M. On diseases of the skin including the exantemata. London: New Sydenham Society, 1875; 1-274 (Cit. en 1)

  16. Von Hebra F. Acute exantheme und hautkranheiten. Handbuch der Speciellen Pathologie und Therapie. Erlangen: Verlag von Ferdinand von Enke, 1860: 198-200 (Cit. en 28)

  17. Von Hebra F. On diseases of the skin, including the exanthemata. Fagge CH, ed London: The New Sydenham Society, 1866: 285 (Cit. en 28)

  18. Urman F, Weinberg J. Scary eruptions but usually a mild disease: Erythema Multiforme. www.dermatlas.com

  19. Stevens AM, Johnson FC. A new eruptive fever associated with stomatitis and ophtalmia. Am J Dis Child 1992; 24: 526-533

  20. 20.Thomas BA. The so-called Stevens Johnson Syndrome. BMJ. 1950; 1: 1393- 1397

  21. Brice SL, Huff JC, Weston WL. Erythema multiforme. Curr Probl Dermatol 1990; II: 3-26

  22. Volcheck GW. Clinical evaluation and management of drug hypersensitivity. Immunol Allergy Clin N Am 2004; 24: 357-371

  23. Rzan B, Mokhenhaupt, Baur S et al. Epidemiology of Erythema exudativum multiforme majus, Stevens-Johnson syndrome, and Toxic epidermal necrolysis in Germany (1990-1992): Structure and results of a population based registry. J Clin Epidemiol 1996; 49: 749-773

  24. 24.Mockenhaupt M, Schopf E. Epidemiology of dug induced severe skin reactions. Sem Cutan Med Surg 1996; 15: 236-243

  25. Stingeni L, Caraffini S, Assalve D et al. Erythema multiforme-lilce contact dermatitis from budesonide. Contact Dermatitis 1996; 34: 154-155

  26. 26.Gattomo M, Picco P, Gambim C et al. Erythema multiforme-like manifestation and arthritis in 3 year old child with leukocytolastic vasculitis. Clin Exp Rheumatol 1997; 15: 329-332

  27. Muñoz D, Del Pozo MD, Audicana M et al. Erythema multiforme-like eruption from antibiotics of 3 different groups. Contact dermatitis 1996: 34: 227-228

  28. Bolognia J, Jorizzo J, Rapini R et al. Dermatology. Elsevier 2004: 313-216

  29. 29.Weston WL, Brice SL, Jester JD et al. Herpes simplex virus in childhood erythema multiforme. Pediatrics 1992; 89: 32-34

  30. 30.Weston WL, Morelli JG. Herpes simplex virus-associated erythema multiforme in prepubertal children. Arch Dermatol Res 1993; 128: 542-545

  31. Brice SL, Stockert SS, Bunker LD et al. The herpes-specific immune response of individuals with herpes-associated erythema multiforme compared with that of individuals with recurrent herpes labiales. Arch Dermatol Res 1993; 285: 193-196

  32. Schofield JK, Tatnall FM, Leigh IM. Recurrent erythema murliforme: clinical features and treatment in a large series of patients. Br J Dermatol 1993; 128: 542-545

  33. Schoenfield JK, Tanall FM, Leighl IM. Recurrent erythema mulriforme: Clinical features and treatment on a large series of patients. Br J Dermatol 1993; 542-545 34.Weston EL, Brice SL, Jester JD. Herpes simplex vius in a childhood erythema multiforme. Pediatrics 1992; 89: 32-34

  34. Di Lerina V, Lo-Scocco G, Bisiginni G. Erythema multiforme following hepatitis B vaccine. Pediatr Dermatol 1994; 11: 363-364

  35. Drago F, Parodi A, Rebora A. Persistent erythema multiforme: Report of two new cases an review of the literature. J Am Acad Dermatol 1995; 33: 366-369

  36. Larcher C, Gasser A, Hattmannstorfer R et al. Interaction of HSV-1 Infected Peripheral Blood Mononuclear Cells with Cultured Dermal Microvascular Endothelial Cells: a Potential Model for the Pathogenesis of HSV-1 induced Erythema Multiforme. The Journal of Investigative Dermatology 2001; 116 (1): 150-156

  37. Ng P, Jiang Y, Hee H et al. Detection of Herpes simplex Virus Genomic DNA in Various Subsets of Erythema mutliforme by Polymerase Chain Reaction. Dermatology 2003; 207: 349-353

  38. Seishima M, Oyama Z, Yamamura M. Erythema multiforme Associated with Citomegalovirus Infection in Nonimmunosuppressed Patients. Dermatology 2001; 203: 299-302 40.Assier H, Bastuji-Garin S, Revuz J et al. Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes. Arch Dermatol 1995; 131 (5): 539-543

  39. Roujeau JC. Stevens-Johnson syndrome and toxic epidermal necrolysis are severity variants of the same disease which differs from erythema multiforme. J Dermatol 1997; 24 (11): 726-729

  40. Pruksachatkunakorn C. Erythema multiforme. Emedicine 2005

  41. Scofield JK, Tatnal FM, Brown J et al. Recurrent erythema multiforme: Tissue typing in a large series of patients. Br J Dermatol 1994; 131: 532-535

  42. 44.Rasmussen J. Erythema Multiforme: a Practical Approach to Recent Advances. Pediatric Dermatology 2002; 19 (1): 82-84

  43. Kaur S, Thami G, Kanwar A et al. Kikuchi Disease with Facial Rash and Erythema Multiforme. Pediatric Dermatology 2001; 18 (5): 403-405

  44. 46.Kokuba H, Aurelian L, Burnett J. Herpes Simplex Virus Associated Erythema Multiforme (HAEM) is Mechanistically Distinct from Drug-Induced Erythema Mutliforme: Interferon – Á is expressed in HAEM Lesions and Tumor Necrosis Factor in Drug-Induced Erythema Multiforme Lesions. The Journal of Investigative Dermatology 1999; 113 (5): 808-815

  45. Chrysomaly E, Lozada-Nur F, Dekker N et al. Apoptosis in oral erythema. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics 1997; 83 (2): 272-280

  46. Brice SL, Stockert SS, Bunker JD et al. The herpes-specific imune response of individuals with herpes-associated erythema multiforme compared with that of individuals with recurrent herpes labialis. Arch Dermat Res 1993; 285: 193-196

  47. 49.Paquet P, Pierard GE. Erythema multiforme and toxic epidermal necrolysis: A comparative study. Am J Dermatopathol 1997; 19: 127-132

  48. Darragh TM, Egbert BM, Berger TG et al. Identification of herpes simplex virus DNA in lesions of erythema multiforme by the polymerase chain reaction. J Am Acad Dermatol 1991; 24: 23-26

  49. Weston WL. What is erythema multiforme? Pediatr Ann 1996; 25: 106-109

  50. Dikland WJ, Oranje AP, Stolz E et al. Erythema multiforme un childhood and early infancy. Pediatr Dermatol 1986; 3: 135-139

  51. Huff JC, Weston WL. Recurrent erythema multiforme in childhood and early infancy. Pediatr Dermatol 1986; 3: 135-139

  52. Huff JC, Eston WL. Isomorphic phenomenon in erythema multiforme. Clin Exp Dermatol 1983; 8: 409-413

  53. Farthing PM, Maragou P, Coates M et al. Characteristics of the oral lesions in patients with cutaneous recurrent erythema multiforme. J Oral Pathol Med 1995; 24: 9-11 56.Weston WL, Brice SL. Atypical forms of herpes simplex associated erythema mutliforme. J Am Acad Dermatol 1998; 39: 124-126

  54. Lozada-Nur F, Gorsky M, Silverman S Jr. Oral erythema multiforme: clinical observations and treatment of 95 patients. Oral Surg Oral Med Oral Pathol 1998; 67: 36-40

  55. Howland WW, Golitz LE, Huff JC et al. Erythema multiforme: clinical, histopathologic and immunologic study. J Am Acad Dermatol 1984; 10: 438-446

  56. Tatnall FM, Schofield JK, Leigh IM. A double-blind, placebo-controlled trial os continous acyclovir therapy in recurrent erythema multiforme. Br J Dermatol 1995; 132: 267-270

  57. 60.Wolf P, Soyer HP, Fink-Puches R et al. Recurrent post-herpetic erythema multiforme mimicking polymorphic light and juvenile spring eruption: report of two cases in young boys. Br J Dermatol 1994; 131: 364-367

  58. Revuz J. New advances in severe adverse drugs reactions. Dermatologic Clinics 2001; 19 (4)

  59. 62.Ackerman B. Histologic diagnosis of inflamatory skin diseases. Williams & Wilkins 1997: 352-654

  60. Ono F, Sharma B, Smith C et al. CD34+ Cells in the Peripheral Blood Transport Herpes Simplex Virus DNA Fragments to the Skin of Patients with Erythema Multiforme (HAEM). The Journal of Investigative Dermatology 2005; 124: 1215-1224

  61. 64.Paquet P, Pièrard GE. Erythema Multiforme and Toxic Epidermal Necrolysis: a comparative study. The American Journal of Dermatopathology 1997; 19 (2): 127-132

  62. Brice SL, Leahy MA, Ong L et al. Examination of the non-involved skin, previously involved skin and peripheral blood for herpes simplex virus DNA in patients with recurrent herpes associated erythema multiforme. J Cutan Pathol 1994; 21: 408-412

  63. 66.Weston JA, Weston WL. The overdiagnosis of erythema multiforme. Pediatrics 1992; 89: 802

  64. Tamayo- Sanchez L, Ruiz-Madonado R, Lateraza AM et al. Acute annular urticaria in infants and children. Pediatr Dermatol 1997; 14: 231-234

  65. 68.Marinho L, Haj M, Pereira L et al. Lip adhesion: An unusual complication of erythema multiforme. Oral Medicine 1999

  66. 69.Martínez A, Atherton D. High-Dose Systemic Corticosteroids Can Arrest Recurrences of Severe Mucocutaneous Erythema Multiforme. Pediatric Dermatology 2000; 17 (2): 87-90

  67. 70.Orozco-Covarrubias ML, Laterza AM, Tamayo-Sánchez L et al. Edema agudo hemorrágico del lactante (púrpura en escarapela). Med Cutan Ibero Lat Am 1990; 18: 392-396

  68. Tanall FM, Schoield JK, Leigh IM. A double blind placebo controlled trial of continuos acyclovir therapy in recurrent erythema multiforme. Br J Dermatol 1995; 132: 267-270

  69. Spurance SL, Tyring SK, De Gregorio B et al. A large-scale, placebocontrolled, dose-ranging trial of perioral valacyclovir for episodic treatment of recurrent herpes genitalis. Arch Intern Med 1996; 156: 1729-1735

  70. Duhra P, Paul CJ. Continous eritema multiform clearing on dapsone. Br J Dermatol 1988; 118: 731

  71. Rusell JR. Azathioprine therapy in the management of persistent erythema multiforme. Br J Dermatol 1989; 105: 456-458

  72. Cherovati K, Souteyrand P et al. Treatment par thalidomide de l´erytheme polymorphic chronique fome recidivant et subintrate. Etude rétrospective de 26 malades. Ann Dermatol Veneorol 1996; 123: 375-377

  73. Bysterin JC. Erythema multiforme with mucous membrane involvement and Stevens-Johnson Syndrome are clinically different disoirders. Arch Dermatol 1996; 711: 12 Volumen 4 / Número




2020     |     www.medigraphic.com